COO
The Cooper Companies, Inc
NASDAQ: COO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$61.34
-2.77% today
Updated 2026-04-29
Market cap
$11.97B
P/E ratio
30.52
P/S ratio
2.88x
EPS (TTM)
$2.01
Dividend yield
—
52W range
$61 – $90
Volume
2.1M
The Cooper Companies, Inc (COO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
9.67%
Operating margin
20.80%
ROE
4.87%
ROA
3.64%
Debt/equity
0.34x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $858.96M | $66.23M | 61.23% | 13.14% | 7.71% |
| 2007 | $950.64M | $-11.19M | 54.65% | 4.82% | -1.18% |
| 2008 | $1.06B | $65.48M | 57.38% | 11.94% | 6.16% |
| 2009 | $1.08B | $100.55M | 55.21% | 13.87% | 9.31% |
| 2010 | $1.16B | $112.80M | 58.41% | 16.39% | 9.74% |
| 2011 | $1.33B | $175.43M | 60.47% | 17.10% | 13.18% |
| 2012 | $1.45B | $248.34M | 63.94% | 19.61% | 17.18% |
| 2013 | $1.59B | $296.15M | 64.67% | 19.27% | 18.65% |
| 2014 | $1.72B | $269.86M | 63.55% | 17.84% | 15.71% |
| 2015 | $1.80B | $203.52M | 59.56% | 13.17% | 11.33% |
| 2016 | $1.97B | $273.92M | 59.64% | 16.48% | 13.93% |
| 2017 | $2.14B | $372.90M | 63.85% | 20.06% | 17.43% |
| 2018 | $2.53B | $139.90M | 64.45% | 15.92% | 5.52% |
| 2019 | $2.65B | $466.70M | 66.21% | 20.60% | 17.59% |
| 2020 | $2.43B | $238.40M | 63.14% | 12.83% | 9.81% |
| 2021 | $2.92B | $2.94B | 66.92% | 17.31% | 100.76% |
| 2022 | $3.31B | $385.80M | 64.67% | 15.34% | 11.66% |
| 2023 | $3.59B | $294.20M | 65.62% | 14.84% | 8.19% |
| 2024 | $3.90B | $392.30M | 66.64% | 18.12% | 10.07% |
| 2025 | $4.09B | $374.90M | 60.67% | 16.69% | 9.16% |